New York,cats of catthulhu New York--(Newsfile Corp. - May 1, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in PharmaCielo Ltd. (OTCQX: PCLOF) ("PharmaCielo" or the "Company") of the May 5, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi logo

If you invested in PharmaCielo stock or options between June 21, 2019 and March 2, 2020

and would like to discuss your legal rights,

click here

:

www.faruqilaw.com/PCLOF

.

There is no cost or obligation to you.

You can also contact us by calling

Richard Gonnello

toll free at

877-247-4292

or at

212-983-9330

or by sending an e-mail to

[email protected]

.

CONTACT:

FARUQI & FARUQI, LLP

685 Third Avenue, 26

th

Floor

New York, NY 10017

Attn: Richard Gonnello, Esq.

[email protected]

Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all those who purchased PharmaCielo securities between June 21, 2019 and March 2, 2020 (the "Class Period"). The case,

Daniel Gabbard v. PharmaCielo Ltd. et al

, No. 20-cv-02182 was filed on March 6, 2020, and has been assigned to Judge Philip S. Gutierrez.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) PharmaCielo engaged in an undisclosed related party transaction with General Extract; (2) PharmaCielo engaged in misleading transactions and loans with General Extract and XPhyto; (3) PharmaCielo's Research Technology and Processing Centre was never on-schedule and is delayed; (4) the Rionegro facility is located on a floodplain and contaminated with mold and pesticides from its previous tenants; (5) PharmaCielo's Cauca Department land has never been utilized by the Company and is idle; and (6) as a result , Defendants' public statements were materially false and/or misleading at all relevant times.

Specifically, on March 2, 2020, Hindenburg Research published a report (the "Report") explaining that PharmaCielo had failed to disclose: (1) transactions with related parties; (2) misleading business transactions and loans with General Extract and XPhyto; (3) the delayed state of its Research Technology and Processing Centre's construction; and (4) the poor state of its Rionegro Growing Facility.

On this news, PharmaCielo's stock fell from a closing price of $1.42 per share over the next two trading days to $0.9068 per share on March 3, 2020- a $0.5132 or 36.14% drop.

Story continues

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding PharmaCielo's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (

www.faruqilaw.com

). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit

https://www.newsfilecorp.com/release/55240

View comments

• ·Gold ETFs Attain Record YTD Inflows Amid Global Uncertainties
• ·Hedge Funds Aren’t Done Buying Euronav NV (EURN)
• ·Coronavirus slows, but doesn't stop real estate lending: Report
• ·Broadcom Inc. (AVGO) Stock Moves -1.58%: What You Should Know
• ·Managers’ transactions - 1
• ·European Stocks Seen Higher; U.S. Election in Spotlight
• ·Genco Shipping & Trading (GNK) Lags Q3 Earnings and Revenue Estimates
• ·Wall Street dives 4% as virus pandemic fears intensify
• ·Is iShares Emerging Markets Dividend ETF (DVYE) a Strong ETF Right Now?
• ·Skeljungur hf.: Changes to terms in market making agreements
• ·Xtierra Announces $1 Million Financing
• ·Voya: 3Q Earnings Snapshot
• ·Daseke Sees Flatbed Softness Continuing Through First Half Of 2020
• ·Russia's ruling party backs idea to allow Putin to run again for president - RIA
• ·Glencore commits to net zero emissions by 2050
• ·Big cash holdings in Europe signal unease over stock market outlook